Therapy-Related Myelodysplastic Syndrome Active Not Recruiting Phase 2 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs